How Does the RIPCORD 2 Trial Differ from Previous Studies of FFR?

How Does the RIPCORD 2 Trial Differ from Previous Studies of FFR?

In the RIPCORD 2 trial, the clinical significance of fractional flow reserve (FFR) measurement was ascertained through use of a specific patient group. Because adding the systemic FFR measurement in clinical practice would not prevent clinical events, the benefit of FFR is limited only for specific patient groups.

TCROSS NEWS asked Dr. Hitoshi Matsuo, Gifu Heart Center, what distinguishes this from previous studies that have reported on the benefits of FFR.

Summary of the RIPCORD 2 Trial The result of RIPCORD 2 trial was not favor in routine use of FFR at...
Continue reading this article
Select an option below:
Go beyond the guidelines
A portal site of complex catheter intervention techniques
About TCROSS NEWS Global

TCROSS NEWS Global is an online medical journal that provides valuable information on Cardiovascular medicine to medical professionals worldwide.
We bring you the latest findings and trends in all areas of cardiovascular medicine. Please register and subscribe for unlimited access to quality Cardiovascular News!

Introducing the main contents
Conference Reports
Conference Reports
Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!
Complex PCI Cases
Complex PCI Cases
Features case reports on patients with complex lesions encountered in daily clinical practice.
Live Demonstration Courses
Live Demonstration CoursesComing soon
In this section you will find live videos of catheter interventions for complex lesions.
What is TCROSS NEWS GLOBAL?
TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Learn more about TCROSS NEWS Global

Recommendations

Long-term Outcomes in Diabetic Patients with FFR(-)/TCFA(+) - COMBINE OCT-FFR Trial, Experts Read
Long-term Outcomes in Diabetic Patients with FFR(-)/TCFA(+) - COMBINE OCT-FFR Trial, Experts Read
opinion
What Do the Results of the FLOWER-MI Trial Indicate?
What Do the Results of the FLOWER-MI Trial Indicate?
opinion
The Consideration of Antiplatelet Therapy after DES Implantation in HBR Patients from the MASTER DAPT Study
The Consideration of Antiplatelet Therapy after DES Implantation in HBR Patients from the MASTER DAPT Study
opinion
PICK UP
Case Sharing: Management of ACS with 36×39×36 mm Giant Coronary Aneurysm Thrombus Occlusion
case report
Case Sharing: Management of ACS with 36×39×36 mm Giant Coronary Aneurysm Thrombus Occlusion
Case Sharing: A Case of EVT for Salvage of ALI after VA-ECMO Introduction from Limited Puncture Site
case report
Case Sharing: A Case of EVT for Salvage of ALI after VA-ECMO Introduction from Limited Puncture Site
TTT 2024 - Faculty from Taiwan and Japan Discuss Complex Cases
Other Scientific Meetings
TTT 2024 - Faculty from Taiwan and Japan Discuss Complex Cases
A Peek into Southeast Asia's Scientific Meetings: Cardiovascular Intervention Association of Thailand, CIAT 2023
Other Scientific Meetings
A Peek into Southeast Asia's Scientific Meetings: Cardiovascular Intervention Association of Thailand, CIAT 2023
Cardiovascular Intervention Association of Thailand's 14th Annual Conference, CIAT 2023: Part 2
Other Scientific Meetings
Cardiovascular Intervention Association of Thailand's 14th Annual Conference, CIAT 2023: Part 2